Short Interest in Hikma Pharmaceuticals PLC (OTCMKTS:HKMPY) Grows By 24.9%

Hikma Pharmaceuticals PLC (OTCMKTS:HKMPY) was the target of a significant growth in short interest during the month of January. As of January 15th, there was short interest totaling 2,189 shares, a growth of 24.9% from the December 31st total of 1,752 shares. Based on an average trading volume of 1,935 shares, the short-interest ratio is currently 1.1 days. Based on an average trading volume of 1,935 shares, the short-interest ratio is currently 1.1 days.

Hikma Pharmaceuticals Stock Up 2.5%

Hikma Pharmaceuticals stock traded up $1.06 during mid-day trading on Tuesday, hitting $43.43. 411 shares of the stock were exchanged, compared to its average volume of 1,657. Hikma Pharmaceuticals has a 12 month low of $39.93 and a 12 month high of $59.26. The firm’s fifty day simple moving average is $41.93 and its two-hundred day simple moving average is $45.61.

About Hikma Pharmaceuticals

Hikma Pharmaceuticals is a multinational pharmaceutical company founded in Amman, Jordan, in 1978. Headquartered in London, the company develops, manufactures and markets a broad range of branded and non-branded generic medicines, as well as speciality injectable products. Over four decades, Hikma has grown from a regional pharmaceutical supplier to a global healthcare provider, maintaining a focus on quality manufacturing and regulatory compliance.

The company operates across three core business segments: branded generics, speciality injectables and non-branded generics.